Meetings/Workshops on Immunology and allergic diseases in Canada

Submit a meeting

Select a location:
Canada (5) - China (1) - France (1) - Germany (4) - Iran (1) - Ireland (1) - Italy (2) - Japan (1) - Mexico (1) - Netherlands (1) - Oman (1) - Portugal (1) - Russia (1) - Spain (1) - Sri Lanka (1) - Switzerland (3) - United Kingdom (1) - United States (16) - ALL COUNTRIES (43)

1
Keystone Symposia: Regulation and Dysregulation of Innate Immunity in Disease
18 Feb 2018 - 22 Feb 2018 • Vancouver, British Columbia, Canada
Abstract:
The innate immune system is fundamental to protect us from pathogens. Although the core components were first elucidated in model organisms such as Drosophila and mice, exactly how they are regulated in human health and contribute to disease remains to be fully defined. Over the past several years, our ability to study the innate immune response has been enabled by a number of transformative tools that can be used to assess gene expression, cellular physiology and gene function. Such technological advances have begun to reveal new components of the innate immune system and have led to a better understanding of its regulation and dysregulation. Importantly, these new insights have allowed us to better understand the pathophysiological basis of certain human diseases and to identify new therapeutic targets to alleviate them. This conference aims to gather different view-points on the field of innate immunity to discuss advances in signaling and regulatory networks and to understand how their dysregulation contributes to immunopathologies and auto-inflammatory conditions.
Contact:
Attendee Services;     Phone: [970.262.1230];     Email: info@keystonesymposia.org
Topics:
innate immunity, immunology
Event listing ID:
964029
2
Keystone Symposia: Antibodies as Drugs - Translating Molecules into Treatments
25 Feb 2018 - 01 Mar 2018 • Whistler, BC, Canada
Abstract:
Antibodies carry an enormous potential in prophylaxis and treatment of human disease. Antibody therapies may be divided into two distinct but highly related disciplines. First, antibodies can be elicited de novo using vaccines. Our understanding of what constitutes an effective antibody response at the molecular level and the science of eliciting such antibodies in vivo is progressing rapidly. Second, isolated antibodies represent powerful drugs when developed as biopharmaceuticals, as demonstrated by the ever-expanding list of approved molecules as well as by the large number of antibody products in development in a wide range of therapeutic areas. The antibody landscape is changing as the field has moved from empirical to knowledge-based, designer approaches for which understanding of mechanisms of action at the molecular level is critical. Translating such basic knowledge into novel products and applications requires scientists from many disciplines including structural and cellular immunology, biology, engineering, chemistry and medicine to interact closely. Consequently, the field of antibody-based vaccines and therapeutics has become an interface area where experts meet and work together. The 2018 Keystone Symposia antibodies conference aims to provide a platform for knowledge-sharing from the molecular to the systems level to navigate the newest developments and insights to prevent, treat and cure major human diseases.
Contact:
Attendee Services;     Phone: [970.262.1230];     Email: info@keystonesymposia.org
Topics:
vaccines, antibodies, drug development, immunology, translational medicine, cancer, biologics, macromolecular chemistry
Event listing ID:
975794
3
Keystone Symposia - Cancer Immunotherapy: Combinations
23 Mar 2018 - 27 Mar 2018 • Montreal, Québec, Canada
Abstract:
By 2025, most patients with cancer will receive immunotherapy as part of their treatment regimen. This symposium will cover the most critical topics integral to this vision: How can we integrate, sequence or combine immunotherapy with standard-of-care cytotoxic therapy, radiotherapy and targeted therapies? Which preclinical models are best predictive of combination approaches? How do we combine immune agonists as well as molecules inhibiting immune-suppressive pathways with checkpoint inhibitors? What are the rational combinations for cancer vaccines and viro-therapy? Which combinatorial approaches could prevent or treat adaptive mechanisms of resistance? Most immunotherapies are being developed in isolation, or being tested as single agents in preclinical models or in clinical studies. This conference helps to address the gaps in knowledge of how and when to combine therapies, and how to integrate immunotherapy into current standard-of-care or novel targeted therapy approaches – both preclinical and clinical. Overall, the objectives of this meeting are to: 1) Elucidate rational combinations for immunotherapy; 2) Discuss preclinical and other models to inform combinatorial approaches; 3) Understand the relevance for biomarker approaches; and 4) Provide insights into the latest preclinical and clinical data for immunotherapy combinations.
Contact:
Attendee Services;     Phone: [970.262.1230];     Email: info@keystonesymposia.org
Topics:
Cancer, Basic Mechanisms, Drug Discovery, Immunology
Event listing ID:
980251
Related subject(s):
4
Clinical Immunology Society Annual Meeting 2018
26 Apr 2018 - 29 Apr 2018 • Toronto, Canada
5
Canadian Society For Immunology 31st Annual Conference 2018
01 Jun 2018 - 04 Jun 2018 • London, Canada
Event listing ID:
994114

View all listed conferences in Canada.



Conference-Service.com offers, as part of its business activities, a directory of upcoming scientific and technical meetings. The calendar is published for the convenience of conference participants and we strive to support conference organisers who need to publish their upcoming events. Although great care is being taken to ensure the correctness of all entries, we cannot accept any liability that may arise from the presence, absence or incorrectness of any particular information on this website. Always check with the meeting organiser before making arrangements to participate in an event!

AIP Conference Proceedings
Last updated: 31 January 2018